Recro Pharma, Inc. (31) | Business Finance (15)

Browse by Subcategory

Recent Contracts

Form of Non-Qualified Stock Option Award Agreement (Filed With SEC on February 26, 2021)
Fifth Amendment to Credit Agreement and Investment Documents, dated as of February 19, 2021, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on February 23, 2021)
Note dated May 12, 2020, between Recro Pharma, Inc. and PNC Bank, National Association (Filed With SEC on May 15, 2020)
Partial Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and... (Filed With SEC on November 26, 2019)
Agreement, dated March 25, 2019, by and among Recro Pharma, Inc., Engine Capital, L.P., Engine Jet Capital, L.P., Engine Investments, LLC, and Arnaud Ajdler (Filed With SEC on March 28, 2019)
Registration Rights Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 19, 2019)
Form of Award Agreement for Restricted Stock Units (Filed With SEC on February 26, 2021)
Second Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated February 26, 2021 (Filed With SEC on February 26, 2021)
Stock Issuance Agreement, dated as of February 19, 2021 by and between Recro Pharma, Inc., Athyrium Opportunities II Acquisition LP and Athyrium Opportunities III Acquisition LP (Filed With SEC on February 23, 2021)
Fourth Amendment to Credit Agreement and Investment Documents, dated as of November 5, 2020, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on November 9, 2020)
First Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated August 7, 2020 (Filed With SEC on August 10, 2020)
Third Amendment to Credit Agreement and Release Agreement, dated as of October 22, 2019, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on November 8, 2019)
Second Amendment to Credit Agreement and Investment Documents, dated February 28, 2019, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party... (Filed With SEC on March 4, 2019)
Common Stock Purchase Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 19, 2019)
First Amendment to Credit Agreement and Investment Documents, dated December 28, 2018, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party... (Filed With SEC on January 4, 2019)